AMW GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AMW GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11177
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AMW GmbH (AMW) is a pharmaceutical company that develops and manufactures drug delivery systems for treatment in the areas of oncology, neurology, dermatology and pain. The company designs and develops novel transdermal drug delivery systems, microchip controlled patches and biodegradable subcutaneous implants for the treatment of various hormone responding tumors, chronic pain and psychiatric diseases. Its products for licensing include Goserelin implant, Leuprorelin implant, Buprenorphin patch and Rivastigmin patch. AMW offers development partnerships with open and transparent collaboration with licensees for exclusive products. The company develops patented technologies for the active control of drug releasing pharmaceuticals. AMW is headquartered in Warngau, Germany.

AMW GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AMW GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AMW GmbH, Medical Devices Deals, 2012 to YTD 2018 9
AMW GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AMW GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
AMW Receives USD29.6 Million of Financing 11
AMW Raises USD6.4 Million in Venture Financing 12
AMW Raises USD9 Million in Venture Financing 13
AMW Raises Funds in Venture Financing 15
AMW Raises Funds in Third Round of Financing 16
Private Equity 17
AMW to Sell Shares to Hybio Pharma and YF Capital Led Consortium 17
AMW GmbH – Key Competitors 19
AMW GmbH – Key Employees 20
AMW GmbH – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Government and Public Interest 22
Dec 21, 2017: Investment Plan for Europe: EIB grants financing to pharmaceutical company AMW 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
AMW GmbH, Pharmaceuticals & Healthcare, Key Facts 2
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AMW GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AMW GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
AMW GmbH, Medical Devices Deals, 2012 to YTD 2018 9
AMW GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AMW Receives USD29.6 Million of Financing 11
AMW Raises USD6.4 Million in Venture Financing 12
AMW Raises USD9 Million in Venture Financing 13
AMW Raises Funds in Venture Financing 15
AMW Raises Funds in Third Round of Financing 16
AMW to Sell Shares to Hybio Pharma and YF Capital Led Consortium 17
AMW GmbH, Key Competitors 19
AMW GmbH, Key Employees 20

List of Figures
AMW GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AMW GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AMW GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[AMW GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Emerson Electric Co (EMR)-石油・ガス分野:企業M&A・提携分析
    Summary Emerson Electric Co. (Emerson) is a provider of infrastructure technologies and life cycle services for information and communication technology systems. The company offers hardware and software solutions for power, thermal and infrastructure management under the brands of Kop-Flex, jaure, a …
  • Sohu.com Inc. (SOHU):企業の財務・戦略的SWOT分析
    Sohu.com Inc. (SOHU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Genalyte Inc:製品パイプライン分析
    Summary Genalyte Inc (Genalyte) is a healthcare service provider that develops cancer biomarker panels and testing platforms for screening. The company provides technologies such as the Maverick Detection System and Silicon Photonics Biosensor technology. Its Maverick Detection System quantifies the …
  • Taurus International MFG, Inc.:企業の戦略・SWOT・財務情報
    Taurus International MFG, Inc. - Strategy, SWOT and Corporate Finance Report Summary Taurus International MFG, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Microsoft Corp (MSFT):医療機器:M&Aディール及び事業提携情報
    Summary Microsoft Corporation (Microsoft) is a technology-based company that develops, licenses, and supports software products, services, and devices. The company offers a comprehensive range of operating systems, cross-device productivity applications, server applications, business solution applic …
  • Main Line Health System:企業の戦略的SWOT分析
    Main Line Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Evergreen Packaging Llc:企業の戦略・SWOT・財務分析
    Evergreen Packaging Llc - Strategy, SWOT and Corporate Finance Report Summary Evergreen Packaging Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Zynerba Pharmaceuticals Inc (ZYNE)-製薬・医療分野:企業M&A・提携分析
    Summary Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals), formerly AllTranz, Inc., focuses on the development of next-generation synthetic cannabinoid therapeutics. The company’s pipeline product candidates include ZYN002 and ZYN001. Zynerba’s ZYN002 is a synthetic CBD, a non-psychoactive canna …
  • Vienna Insurance Group AG:企業の戦略・SWOT・財務情報
    Vienna Insurance Group AG - Strategy, SWOT and Corporate Finance Report Summary Vienna Insurance Group AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Nuo Therapeutics Inc (AURX):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuo Therapeutics Inc (Nuo Therapeutics), formerly Cytomedix, is a biomedical company that specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, which bind the regenerative capacity of the human body to trigger natural healing. T …
  • Centers for Disease Control and Prevention-医療機器分野:企業M&A・提携分析
    Summary Centers for Disease Control and Prevention (CDC), a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities f …
  • Muhibbah Engineering (M) Bhd:企業の戦略・SWOT・財務情報
    Muhibbah Engineering (M) Bhd - Strategy, SWOT and Corporate Finance Report Summary Muhibbah Engineering (M) Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Anteo Diagnostics Ltd (ADO):医療機器:M&Aディール及び事業提携情報
    Summary Anteo Diagnostics Ltd (Anteo Diagnostics) is a leading medical technology company that develops and commercializes healthcare products. The company along with its subsidiaries provides immunoassays, in-vitro diagnostics, and point of care (PoC) tests to life sciences, bio-separation, clinica …
  • Rafako SA (RFK):企業の財務・戦略的SWOT分析
    Rafako SA (RFK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Diehl Defence Holding GmbH:企業の戦略的SWOT分析
    Diehl Defence Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Raya Holding (RAYA):企業の財務・戦略的SWOT分析
    Raya Holding (RAYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Compagnie Des Alpes Sa
    Compagnie Des Alpes Sa - Strategy, SWOT and Corporate Finance Report Summary Compagnie Des Alpes Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Clarivate Plc (CLVT):企業の財務・戦略的SWOT分析
    Clarivate Plc (CLVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sedia Biosciences Corp:製品パイプライン分析
    Summary Sedia Biosciences Corp (SBC) is a medical device company that offers diagnostic products. The company provides medical devices, diagnostic devices, HIV incidence products, rapid point of care assays and specimen collection devices. It also offers diagnostic products, epidemiological products …
  • Centogene AG:医療機器:M&Aディール及び事業提携情報
    Summary Centogene AG (Centogene) is a biotechnology and genetic diagnostic company which offers genetic testing for rare hereditary disorders. The company provides diagnostic services including whole genome sequencing, whole exome sequencing, clinical exome sequencing, NGS panel genomic, carrier scr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆